Filed: 11/14/2023ACC: 0001104659-23-118095
📋 What this filing means
SOFINNOVA INVESTMENTS, INC. filed this quarterly 13F‑HR report disclosing 57 equity positions with a total reported market value of $1.59B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
57
Positions
$1.59B
Total AUM (reported)
85.76M
Total Shares
Allocation by class
COM$1.13B71.0%
SPONSORED ADR$242.05M15.3%
SHS$52.71M3.3%
CL A$47.53M3.0%
RUSSELL 2000 ETF$39.77M2.5%
TR UNIT$21.37M1.3%
UNIT SER 1$17.91M1.1%
Portfolio Concentration
Top 3$463.03M29.2%
4–10$399.83M25.2%
11–25$501.33M31.6%
Rest$221.05M13.9%
Top 3 weight
29.2%
Top 10 weight
54.4%
Voting Authority Distribution
Total shares with voting rights: 85.76M
Sole
Full voting authority
85.76M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole57
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings57
Rows:
Karuna Therapeutics Inc
SOLEShares1.38M
TypeSH
Market value$233.54M
14.73%
Sole
1.38M
Shared
0.00
None
0.00
Natera Inc
SOLEShares3.10M
TypeSH
Market value$137.20M
8.65%
Sole
3.10M
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares1.36M
TypeSH
Market value$92.29M
5.82%
Sole
1.36M
Shared
0.00
None
0.00
Merck & Co Inc
SOLEShares728.40K
TypeSH
Market value$74.99M
4.73%
Sole
728.40K
Shared
0.00
None
0.00
Ascendis Pharma A/S
SOLEShares754.03K
TypeSH
Market value$70.61M
4.45%
Sole
754.03K
Shared
0.00
None
0.00
RayzeBio Inc
SOLEShares2.42M
TypeSH
Market value$53.71M
3.39%
Sole
2.42M
Shared
0.00
None
0.00
Dexcom Inc
SOLEShares550.20K
TypeSH
Market value$51.33M
3.24%
Sole
550.20K
Shared
0.00
None
0.00
Aerovate Therapeutics Inc
SOLEShares3.76M
TypeSH
Market value$51.01M
3.22%
Sole
3.76M
Shared
0.00
None
0.00
Intuitive Surgical Inc
SOLEShares173.28K
TypeSH
Market value$50.65M
3.19%
Sole
173.28K
Shared
0.00
None
0.00
Vera Therapeutics Inc
SOLEShares3.47M
TypeSH
Market value$47.53M
3.00%
Sole
3.47M
Shared
0.00
None
0.00
Cytokinetics Inc
SOLEShares1.56M
TypeSH
Market value$45.96M
2.90%
Sole
1.56M
Shared
0.00
None
0.00
Elanco Animal Health Inc
SOLEShares3.61M
TypeSH
Market value$40.58M
2.56%
Sole
3.61M
Shared
0.00
None
0.00
IShares TR
SOLEShares225K
TypeSH
Market value$39.77M
2.51%
Sole
225K
Shared
0.00
None
0.00
argenx SE
SOLEShares78.19K
TypeSH
Market value$38.44M
2.42%
Sole
78.19K
Shared
0.00
None
0.00
Exelixis Inc
SOLEShares1.74M
TypeSH
Market value$38.09M
2.40%
Sole
1.74M
Shared
0.00
None
0.00
Immatics NV
SOLEShares3.25M
TypeSH
Market value$37.65M
2.38%
Sole
3.25M
Shared
0.00
None
0.00
Sanofi
SOLEShares695.38K
TypeSH
Market value$37.30M
2.35%
Sole
695.38K
Shared
0.00
None
0.00
Kenvue Inc
SOLEShares1.80M
TypeSH
Market value$36.19M
2.28%
Sole
1.80M
Shared
0.00
None
0.00
IDEXX Laboratories Inc
SOLEShares77.88K
TypeSH
Market value$34.06M
2.15%
Sole
77.88K
Shared
0.00
None
0.00
ImmunoGen Inc
SOLEShares2.05M
TypeSH
Market value$32.46M
2.05%
Sole
2.05M
Shared
0.00
None
0.00
Syndax Pharmaceuticals Inc
SOLEShares1.99M
TypeSH
Market value$28.92M
1.82%
Sole
1.99M
Shared
0.00
None
0.00
IDEAYA Biosciences Inc
SOLEShares1.04M
TypeSH
Market value$27.98M
1.77%
Sole
1.04M
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc
SOLEShares1.21M
TypeSH
Market value$24.31M
1.53%
Sole
1.21M
Shared
0.00
None
0.00
SPDR S&P 500 ETF Trust
SOLEShares50K
TypeSH
Market value$21.37M
1.35%
Sole
50K
Shared
0.00
None
0.00
Replimune Group Inc
SOLEShares1.07M
TypeSH
Market value$18.26M
1.15%
Sole
1.07M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Karuna Therapeutics IncSOLE | COM | 1.38M | SH | $233.54M 14.73% | 1.38M | 0.00 | 0.00 |
Natera IncSOLE | COM | 3.10M | SH | $137.20M 8.65% | 3.10M | 0.00 | 0.00 |
AstraZeneca PLCSOLE | SPONSORED ADR | 1.36M | SH | $92.29M 5.82% | 1.36M | 0.00 | 0.00 |
Merck & Co IncSOLE | COM | 728.40K | SH | $74.99M 4.73% | 728.40K | 0.00 | 0.00 |
Ascendis Pharma A/SSOLE | SPONSORED ADR | 754.03K | SH | $70.61M 4.45% | 754.03K | 0.00 | 0.00 |
RayzeBio IncSOLE | COM | 2.42M | SH | $53.71M 3.39% | 2.42M | 0.00 | 0.00 |
Dexcom IncSOLE | COM | 550.20K | SH | $51.33M 3.24% | 550.20K | 0.00 | 0.00 |
Aerovate Therapeutics IncSOLE | COM | 3.76M | SH | $51.01M 3.22% | 3.76M | 0.00 | 0.00 |
Intuitive Surgical IncSOLE | COM | 173.28K | SH | $50.65M 3.19% | 173.28K | 0.00 | 0.00 |
Vera Therapeutics IncSOLE | CL A | 3.47M | SH | $47.53M 3.00% | 3.47M | 0.00 | 0.00 |
Cytokinetics IncSOLE | COM | 1.56M | SH | $45.96M 2.90% | 1.56M | 0.00 | 0.00 |
Elanco Animal Health IncSOLE | COM | 3.61M | SH | $40.58M 2.56% | 3.61M | 0.00 | 0.00 |
IShares TRSOLE | RUSSELL 2000 ETF | 225K | SH | $39.77M 2.51% | 225K | 0.00 | 0.00 |
argenx SESOLE | SPONSORED ADR | 78.19K | SH | $38.44M 2.42% | 78.19K | 0.00 | 0.00 |
Exelixis IncSOLE | COM | 1.74M | SH | $38.09M 2.40% | 1.74M | 0.00 | 0.00 |
Immatics NVSOLE | SHS | 3.25M | SH | $37.65M 2.38% | 3.25M | 0.00 | 0.00 |
SanofiSOLE | SPONSORED ADR | 695.38K | SH | $37.30M 2.35% | 695.38K | 0.00 | 0.00 |
Kenvue IncSOLE | COM | 1.80M | SH | $36.19M 2.28% | 1.80M | 0.00 | 0.00 |
IDEXX Laboratories IncSOLE | COM | 77.88K | SH | $34.06M 2.15% | 77.88K | 0.00 | 0.00 |
ImmunoGen IncSOLE | COM | 2.05M | SH | $32.46M 2.05% | 2.05M | 0.00 | 0.00 |
Syndax Pharmaceuticals IncSOLE | COM | 1.99M | SH | $28.92M 1.82% | 1.99M | 0.00 | 0.00 |
IDEAYA Biosciences IncSOLE | COM | 1.04M | SH | $27.98M 1.77% | 1.04M | 0.00 | 0.00 |
Zentalis Pharmaceuticals IncSOLE | COM | 1.21M | SH | $24.31M 1.53% | 1.21M | 0.00 | 0.00 |
SPDR S&P 500 ETF TrustSOLE | TR UNIT | 50K | SH | $21.37M 1.35% | 50K | 0.00 | 0.00 |
Replimune Group IncSOLE | COM | 1.07M | SH | $18.26M 1.15% | 1.07M | 0.00 | 0.00 |
Page 1 of 3